VIRTUO
Device
bioMerieux
Total Payments
$15,779
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $6,500 | 1 | 0 |
| 2018 | $9,279 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,779 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Gram-negative Growth and Time to Detection | bioMerieux | $9,279 | 0 |
| Neutralization of carbapenems and cephalosporins and organism recovery on VIRTUO vs. BD FX | bioMerieux | $6,500 | 0 |
Top Doctors Receiving Payments for VIRTUO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hartford, CT | $15,779 | 2 |
Ad
Manufacturing Companies
- bioMerieux $15,779
Product Information
- Type Device
- Total Payments $15,779
- Total Doctors 0
- Transactions 2
About VIRTUO
VIRTUO is a device associated with $15,779 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is bioMerieux.
Payment data is available from 2018 to 2019. In 2019, $6,500 was paid across 1 transactions to 0 doctors.
The most common payment nature for VIRTUO is "Unspecified" ($15,779, 100.0% of total).
VIRTUO is associated with 2 research studies, including "Gram-negative Growth and Time to Detection" ($9,279).